Correlation Between Unicycive Therapeutics and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Unicycive Therapeutics and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Sonnet Biotherapeutics.
Diversification Opportunities for Unicycive Therapeutics and Sonnet Biotherapeutics
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Unicycive and Sonnet is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Sonnet Biotherapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to under-perform the Sonnet Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Unicycive Therapeutics is 1.85 times less risky than Sonnet Biotherapeutics. The stock trades about -0.3 of its potential returns per unit of risk. The Sonnet Biotherapeutics Holdings is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 160.00 in Sonnet Biotherapeutics Holdings on November 2, 2024 and sell it today you would earn a total of 13.00 from holding Sonnet Biotherapeutics Holdings or generate 8.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Unicycive Therapeutics |
| Sonnet Biotherapeutics |
Unicycive Therapeutics and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Sonnet Biotherapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |